Applied Filter(s) Clear Filter


Type:

Industry: Pharma & Biotech

Therapy Area:

Category:

Electrosurgery Market

Report ID: PNPH1409 Industry: Pharma & Biotech

The Electrosurgery market is projected to grow significantly in the coming years. The market, which was valued at USD 6.4 Bn in 2023, is anticipated to reach USD 11.9 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2024 to 2033.

AI in Oncology Market

Report ID: PNPH1408 Industry: Pharma & Biotech

The AI in Oncology market is projected to grow significantly in the coming years. The market, which was valued at USD 2.4 Bn Bn in 2023, is anticipated to reach USD 18.26 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 22.5% during the forecast period of 2024 to 2033.

Pharmaceutical Packaging Equipment Market

Report ID: PNPH1407 Industry: Pharma & Biotech

The Pharmaceutical Packaging Equipment market is projected to grow significantly in the coming years. The market, which was valued at USD 9 Bn in 2023, is anticipated to reach USD 17.7 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2024 to 2033.

Neonatal Medicine Market

Report ID: PNPH1406 Industry: Pharma & Biotech

The Neonatal Medicine market is projected to grow significantly in the coming years. The market, which was valued at USD 4,420.46 Mn in 2023, is anticipated to reach USD 8,695.71 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2024 to 2033.

Biosurgery Market

Report ID: PNPH1405 Industry: Pharma & Biotech

The Biosurgery market is projected to grow significantly in the coming years. The market, which was valued at USD 13.6 Bn in 2023, is anticipated to reach USD 23.23 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2033.

Geriatric Care Services Market

Report ID: PNPH1404 Industry: Pharma & Biotech

The Geriatric Care Services market is projected to grow significantly in the coming years. The market, which was valued at USD 1072.2 Bn in 2023, is anticipated to reach USD 1920.15 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.0% during the forecast period of 2024 to 2033.

Gene Editing Market

Report ID: PNPH1403 Industry: Pharma & Biotech

The Gene Editing market is projected to grow significantly in the coming years. The market, which was valued at USD 5.0 Bn in 2023, is anticipated to reach USD 20.23 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 15.0% during the forecast period of 2024 to 2033.

Animal Healthcare Market

Report ID: PNPH1402 Industry: Pharma & Biotech

The Animal Healthcare market is projected to grow significantly in the coming years. The market, which was valued at USD 147.50 Bn in 2023, is anticipated to reach USD 244.72 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2024 to 2033.

Assisted Reproductive Technology Market

Report ID: PNPH1401 Industry: Pharma & Biotech

The Assisted Reproductive Technology market is projected to grow significantly in the coming years. The market, which was valued at USD 28.2 Bn in 2023, is anticipated to reach USD 61.45 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2033.

DNA Sequencing Market

Report ID: PNPH1400 Industry: Pharma & Biotech

The DNA Sequencing market is projected to grow significantly in the coming years. The market, which was valued at USD 12 Bn in 2023, is anticipated to reach USD 65.52 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 18.5% during the forecast period of 2024 to 2033.

Wearable Medical Devices Market

Report ID: PNPH1399 Industry: Pharma & Biotech

The Wearable Medical Devices market is projected to grow significantly in the coming years. The market, which was valued at USD 40.5 Bn in 2023, is anticipated to reach USD 115 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2024 to 2033.

Healthcare Staffing Market

Report ID: PNPH1398 Industry: Pharma & Biotech

The Healthcare Staffing market is projected to grow significantly in the coming years. The market, which was valued at USD 39.48 Bn in 2023, is anticipated to reach USD 77.66 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2024 to 2033.

Nasal Drug Delivery Technology Market

Report ID: PNPH1397 Industry: Pharma & Biotech

The Nasal Drug Delivery Technology market is projected to grow significantly in the coming years. The market, which was valued at USD 141.38 Bn in 2023, is anticipated to reach USD 3.7 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2033.

AI in Healthcare Market

Report ID: PNPH1396 Industry: Pharma & Biotech

The AI in Healthcare market is projected to grow significantly in the coming years. The market, which was valued at USD 19.2 Bn in 2023, is anticipated to reach USD 498.65 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 38.5% during the forecast period of 2024 to 2033.

Cancer Immunotherapy Market

Report ID: PNPH1395 Industry: Pharma & Biotech

The Cancer Immunotherapy market is projected to grow significantly in the coming years. The market, which was valued at USD 106.3 Bn in 2023, is anticipated to reach USD 345.19 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2033.

Immunotherapy Drugs Market

Report ID: PNPH1394 Industry: Pharma & Biotech

The Immunotherapy Drugs market is projected to grow significantly in the coming years. The market, which was valued at USD 120.3 Bn in 2023, is anticipated to reach USD 272 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2024 to 2033.

Oral Solids/Tablets Packed as Wallet Market

Report ID: PNPH1393 Industry: Pharma & Biotech

The Oral Solids/Tablets Packed as Wallet market is projected to grow significantly in the coming years. The market, which was valued at USD 545 Mn in 2023, is anticipated to reach USD 1023.04 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2024 to 2033.

Digital Therapeutics Market

Report ID: PNPH1392 Industry: Pharma & Biotech

The Digital Therapeutics market is projected to grow significantly in the coming years. The market, which was valued at USD 6.0 Bn in 2023, is anticipated to reach USD 45.66 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 22.5% during the forecast period of 2024 to 2033.

Generative AI in Healthcare Market

Report ID: PNPH1391 Industry: Pharma & Biotech

The Generative AI in Healthcare market is projected to grow significantly in the coming years. The market, which was valued at USD 1.7 Bn in 2023, is anticipated to reach USD 27.3 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 32.0% during the forecast period of 2024 to 2033.

AI in Bioinformatics Market

Report ID: PNPH1390 Industry: Pharma & Biotech

The AI in Bioinformatics market is projected to grow significantly in the coming years. The market, which was valued at USD 3.6 Mn in 2023, is anticipated to reach USD 124.29 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 42.5% during the forecast period of 2024 to 2033.

Veterinary Diabetes Market

Report ID: PNPH1389 Industry: Pharma & Biotech

The Veterinary Diabetes market is projected to grow significantly in the coming years. The market, which was valued at USD 2.12 Bn in 2023, is anticipated to reach USD 3.65 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast period of 2024 to 2033.

Veterinary Antibiotics Market

Report ID: PNPH1388 Industry: Pharma & Biotech

The Veterinary Antibiotics market is projected to grow significantly in the coming years. The market, which was valued at USD 11,450.5 Mn in 2023, is anticipated to reach USD 19,745.3 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2024 to 2033.

Veterinary Biologics Market

Report ID: PNPH1387 Industry: Pharma & Biotech

The Veterinary Biologics market is projected to grow significantly in the coming years. The market, which was valued at USD 12,361.81 Mn in 2023, is anticipated to reach USD 22,772.71 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 6.3% during the forecast period of 2024 to 2033.

Veterinary Vaccines Market

Report ID: PNPH1386 Industry: Pharma & Biotech

The Veterinary Vaccines market is projected to grow significantly in the coming years. The market, which was valued at USD 8.5 Bn in 2023, is anticipated to reach USD 15.37 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2024 to 2033.

Veterinary Medicine Market

Report ID: PNPH1385 Industry: Pharma & Biotech

The Veterinary Medicine market is projected to grow significantly in the coming years. The market, which was valued at USD 45.5 Bn in 2023, is anticipated to reach USD 93.78 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2024 to 2033.

3D Bioprinting Market

Report ID: PNPH1384 Industry: Pharma & Biotech

The 3D Bioprinting market is projected to grow significantly in the coming years. The market, which was valued at USD 1.1 Bn in 2023, is anticipated to reach USD 3.7 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2033.

Global Parkinson\'s Diseases Market

Report ID: PNPH1383 Industry: Pharma & Biotech Therapy Area: Neurological Disorder

Parkinson's Disease Market is segmented By Type (Juvenile Parkinson Disease, Young-Onset Parkinson’s Disease, Idiopathic Parkinson Disease), By Age (Adult, Pediatric), By Diagnosis(CT Scan, MRI Scan, DaTSCAN-SPECT scan, PET Scan), By Drug Class (Carbidopa-Levodopa, Carbidopa-Levodopa Infusion, Dopamine Agonists, Monoamine Oxidase B Inhibitors, Catechol O-Methyltransferase Inhibitors, Anticholinergics, Amantadine), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa) – Share, Size, Outlook, And Opportunity Analysis, 2023-2030.

Global Immunotherapy Drugs Market

Report ID: PNPH1382 Industry: Pharma & Biotech

According to Pharmanucleus the immunotherapy drugs market is projected to achieve a Compound Annual Growth Rate (CAGR) of 8.70% between 2023 and 2030. Immunotherapy, a type of cancer treatment, enhances the body's innate immune system to combat cancer cells. It utilizes substances produced by the body or generated in vitro in the laboratory.

Osteosarcoma Market

Report ID: PNPH1381 Industry: Pharma & Biotech

The Osteosarcoma market is projected to grow significantly in the coming years. The market, which was valued at USD 632.62 Mn in 2023, is anticipated to reach USD 1404.20 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 8.3% during the forecast period of 2024 to 2033.

Non-Alcoholic Fatty Liver Disease Market

Report ID: PNPH1380 Industry: Pharma & Biotech

The Non-Alcoholic Fatty Liver Disease market is projected to grow significantly in the coming years. The market, which was valued at USD 1.6 Bn in 2023, is anticipated to reach USD 13.95 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 24.18% during the forecast period of 2024 to 2033.

Non-Hodgkin Lymphoma (NHL) Market

Report ID: PNPH1379 Industry: Pharma & Biotech

The Non-Hodgkin Lymphoma (NHL) market is projected to grow significantly in the coming years. The market, which was valued at USD 9.81 Bn in 2023, is anticipated to reach USD 22.18 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.50% during the forecast period of 2024 to 2033.

Chemotherapy Induced Anemia Market

Report ID: PNPH1378 Industry: Pharma & Biotech

The Chemotherapy Induced Anemia market is projected to grow significantly in the coming years. The market, which was valued at USD 2.41 Bn in 2023, is anticipated to reach USD 4.83 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2033.

Follicular Lymphoma Market

Report ID: PNPH1377 Industry: Pharma & Biotech

The Follicular Lymphoma market is projected to grow significantly in the coming years. The market, which was valued at USD 1495.23 Mn in 2023, is anticipated to reach USD 2366.87 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2033.

Inflammatory Bowel Diseases (IBD) Market

Report ID: PNPH1376 Industry: Pharma & Biotech

The Inflammatory Bowel Diseases (IBD) market is projected to grow significantly in the coming years. The market, which was valued at USD 22.42 Bn in 2023, is anticipated to reach USD 37.58 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.3% during the forecast period of 2024 to 2033.

Gastritis Market

Report ID: PNPH1375 Industry: Pharma & Biotech

The Gastritis market is projected to grow significantly in the coming years. The market, which was valued at USD 175.44 Mn in 2023, is anticipated to reach USD 259.69 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 4.0% during the forecast period of 2024 to 2033.

Liver Function Test Market

Report ID: PNPH1374 Industry: Pharma & Biotech

The Liver Function Test market is projected to grow significantly in the coming years. The market, which was valued at USD 38.24 Bn in 2023, is anticipated to reach USD 75.22 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2024 to 2033.

Uterine Cancer Drugs Market

Report ID: PNPH1373 Industry: Pharma & Biotech

The Uterine Cancer Drugs market is projected to grow significantly in the coming years. The market, which was valued at USD 2.6 Mn in 2023, is anticipated to reach USD 5.88 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2024 to 2033.

Age-Related Macular Degeneration (AMD) Disease - Anti VEGF Market

Report ID: PNPH1372 Industry: Pharma & Biotech

The Age-Related Macular Degeneration (AMD) Disease - Anti VEGF market is projected to grow significantly in the coming years. The market, which was valued at USD 12.78 Bn in 2023, is anticipated to reach USD 18.74 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 3.9% during the forecast period of 2024 to 2033.

Visceral Pain Market

Report ID: PNPH1371 Industry: Pharma & Biotech

The Visceral Pain market is projected to grow significantly in the coming years. The market, which was valued at USD 13.71 Bn in 2023, is anticipated to reach USD 23.87 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period of 2024 to 2033.

AI in Neurology Market

Report ID: PNPH1370 Industry: Pharma & Biotech

The AI in Neurology market is projected to grow significantly in the coming years. The market, which was valued at USD 48.0 Mn in 2023, is anticipated to reach USD 1,408.38 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 40.2% during the forecast period of 2024 to 2033.

Pediatric Growth Hormone Deficiency Market

Report ID: PNPH1369 Industry: Pharma & Biotech

The Pediatric Growth Hormone Deficiency market is projected to grow significantly in the coming years. The market, which was valued at USD 3.45 Bn in 2023, is anticipated to reach USD 13.96 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 15.0% during the forecast period of 2024 to 2033.

Cluster Headache Drugs Market

Report ID: PNPH1368 Industry: Pharma & Biotech

The Cluster Headache Drugs market is projected to grow significantly in the coming years. The market, which was valued at USD 369.14 Mn in 2023, is anticipated to reach USD 692.93 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2024 to 2033.

Lyophilized Injectable Drugs Market

Report ID: PNPH1367 Industry: Pharma & Biotech

The Lyophilized Injectable Drugs market is projected to grow significantly in the coming years. The market, which was valued at USD 3,196.39 Mn in 2023, is anticipated to reach USD 5,833.17 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast period of 2024 to 2033.

Down Syndrome Market

Report ID: PNPH1366 Industry: Pharma & Biotech

The Down Syndrome market is projected to grow significantly in the coming years. The market, which was valued at USD 1,796.27 Mn in 2023, is anticipated to reach USD 6,776.92 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 14.2% during the forecast period of 2024 to 2033.

Live Attenuated Vaccines Market

Report ID: PNPH1365 Industry: Pharma & Biotech

The Live Attenuated Vaccines market is projected to grow significantly in the coming years. The market, which was valued at USD 18,932.8 Mn in 2023, is anticipated to reach USD 60396.59 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2033.

Advanced Melanoma Market

Report ID: PNPH1364 Industry: Pharma & Biotech

The Advanced Melanoma market is projected to grow significantly in the coming years. The market, which was valued at USD 3.9 Bn in 2023, is anticipated to reach USD 9.15 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2024 to 2033.

Advanced Liver Cancer Market

Report ID: PNPH1363 Industry: Pharma & Biotech

The Advanced Liver Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 8,008.8 Mn in 2023, is anticipated to reach USD 15,033.62 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2024 to 2033.

Adult T-Cell Leukemia Lymphoma Market

Report ID: PNPH1362 Industry: Pharma & Biotech

The Adult T-Cell Leukemia Lymphoma market is projected to grow significantly in the coming years. The market, which was valued at USD 1,915.46 Mn in 2023, is anticipated to reach USD 4,330.82 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2024 to 2033.

Adult Myopia Market

Report ID: PNPH1361 Industry: Pharma & Biotech

The Adult Myopia market is projected to grow significantly in the coming years. The market, which was valued at USD 19.25 Bn in 2023, is anticipated to reach USD 41.56 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.0% during the forecast period of 2024 to 2033.

Adrenocortical Carcinoma Market

Report ID: PNPH1360 Industry: Pharma & Biotech

The Adrenocortical Carcinoma market is projected to grow significantly in the coming years. The market, which was valued at USD 672.3 Mn in 2023, is anticipated to reach USD 860.6 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 2.5% during the forecast period of 2024 to 2033.

Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market

Report ID: PNPH1359 Industry: Pharma & Biotech

The Adeno-Associated Virus (AAV) Vector-Based Gene Therapy market is projected to grow significantly in the coming years. The market, which was valued at USD 5.2 Bn in 2023, is anticipated to reach USD 21.2 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 15.1% during the forecast period of 2024 to 2033.

Acute Respiratory Distress Syndrome (ARDS) Market

Report ID: PNPH1358 Industry: Pharma & Biotech

The Acute Respiratory Distress Syndrome (ARDS) market is projected to grow significantly in the coming years. The market, which was valued at USD 3.1 Bn in 2023, is anticipated to reach USD 5.35 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2024 to 2033.

Acute Pulmonary Embolism Market

Report ID: PNPH1357 Industry: Pharma & Biotech

The Acute Pulmonary Embolism market is projected to grow significantly in the coming years. The market, which was valued at USD 1.79 Bn in 2023, is anticipated to reach USD 3.97 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.3% during the forecast period of 2024 to 2033.

Severe Asthma Market

Report ID: PNPH1356 Industry: Pharma & Biotech

The Severe Asthma market is projected to grow significantly in the coming years. The market, which was valued at USD 22 Bn in 2023, is anticipated to reach USD 36.18 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.1% during the forecast period of 2024 to 2033.

Tardive Dyskinesia Market

Report ID: PNPH1355 Industry: Pharma & Biotech

The Tardive Dyskinesia market is projected to grow significantly in the coming years. The market, which was valued at USD 3.59 Bn in 2023, is anticipated to reach USD 8.74 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 9.3% during the forecast period of 2024 to 2033.

Soft Tissue Sarcoma Market

Report ID: PNPH1354 Industry: Pharma & Biotech

The Soft Tissue Sarcoma market is projected to grow significantly in the coming years. The market, which was valued at USD 3,989.52 Mn in 2023, is anticipated to reach USD 8,533.66 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2024 to 2033.

Small Cell Lung Cancer Market

Report ID: PNPH1353 Industry: Pharma & Biotech

The Small Cell Lung Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 12.1 Bn in 2023, is anticipated to reach USD 31.3 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2033.

Sepsis Market

Report ID: PNPH1352 Industry: Pharma & Biotech

The Sepsis market is projected to grow significantly in the coming years. The market, which was valued at USD 3.8 Bn in 2023, is anticipated to reach USD 8.5 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2024 to 2033.

Schizophrenia Market

Report ID: PNPH1351 Industry: Pharma & Biotech

The Schizophrenia market is projected to grow significantly in the coming years. The market, which was valued at USD 9,480.40 Mn in 2023, is anticipated to reach USD 14,582.49 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 4.4% during the forecast period of 2024 to 2033.

Pulmonary Arterial Hypertension Market

Report ID: PNPH1350 Industry: Pharma & Biotech

The Pulmonary Arterial Hypertension market is projected to grow significantly in the coming years. The market, which was valued at USD 7.66 Bn in 2023, is anticipated to reach USD 12.96 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2024 to 2033.

Presbyopia Market

Report ID: PNPH1349 Industry: Pharma & Biotech

The Presbyopia market is projected to grow significantly in the coming years. The market, which was valued at USD 10.34 Bn in 2023, is anticipated to reach USD 16.6 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 4.9% during the forecast period of 2024 to 2033.

Open Angle Glaucoma Market

Report ID: PNPH1348 Industry: Pharma & Biotech

The Open Angle Glaucoma market is projected to grow significantly in the coming years. The market, which was valued at USD 5.4 Mn in 2023, is anticipated to reach USD 7.99 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 4.0% during the forecast period of 2024 to 2033.

Onychomycosis Market

Report ID: PNPH1347 Industry: Pharma & Biotech

The Onychomycosis market is projected to grow significantly in the coming years. The market, which was valued at USD 3.58 Bn in 2023, is anticipated to reach USD 5.35 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 4.1% during the forecast period of 2024 to 2033.

Natural Killer (NK) Cell Therapeutics Market

Report ID: PNPH1346 Industry: Pharma & Biotech

The Natural Killer (NK) Cell Therapeutics market is projected to grow significantly in the coming years. The market, which was valued at USD 3,126.72 Mn in 2023, is anticipated to reach USD 15,551.42 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 17.4% during the forecast period of 2024 to 2033.

Nasopharyngeal Cancer Market

Report ID: PNPH1345 Industry: Pharma & Biotech

The Nasopharyngeal Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 616.22 Mn in 2023, is anticipated to reach USD 1.2 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2024 to 2033.

Migraine Market

Report ID: PNPH1344 Industry: Pharma & Biotech

The Migraine market is projected to grow significantly in the coming years. The market, which was valued at USD 3.89 Bn in 2023, is anticipated to reach USD 16.58 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 15.6% during the forecast period of 2024 to 2033.

Metastatic Colorectal Cancer Market

Report ID: PNPH1343 Industry: Pharma & Biotech

The Metastatic Colorectal Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 3.5 Bn in 2023, is anticipated to reach USD 5.49 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2024 to 2033.

Malignant Mesothelioma Market

Report ID: PNPH1342 Industry: Pharma & Biotech

The Malignant Mesothelioma market is projected to grow significantly in the coming years. The market, which was valued at USD 285.14 Mn in 2023, is anticipated to reach USD 675.03 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 9.0% during the forecast period of 2024 to 2033.

Liver Cancer Market

Report ID: PNPH1341 Industry: Pharma & Biotech

The Liver Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 9,339.6 Mn in 2023, is anticipated to reach USD 17,813.58 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 6.67% during the forecast period of 2024 to 2033.

Hypothalamic Obesity Market

Report ID: PNPH1340 Industry: Pharma & Biotech

The Hypothalamic Obesity market is projected to grow significantly in the coming years. The market, which was valued at USD 356.3 Mn in 2023, is anticipated to reach USD 820.56 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 8.7% during the forecast period of 2024 to 2033.

Hepatocellular Carcinoma Market

Report ID: PNPH1339 Industry: Pharma & Biotech

The Hepatocellular Carcinoma market is projected to grow significantly in the coming years. The market, which was valued at USD 1.13 Bn in 2023, is anticipated to reach USD 2.49 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 11.1% during the forecast period of 2024 to 2033.

Hepatitis C Market

Report ID: PNPH1338 Industry: Pharma & Biotech

The Hepatitis C market is projected to grow significantly in the coming years. The market, which was valued at USD 62.6 Bn in 2023, is anticipated to reach USD 224.06 Bn Mn by 2033, reflecting a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2024 to 2033.

Hepatitis B Market

Report ID: PNPH1337 Industry: Pharma & Biotech

The Hepatitis B market is projected to grow significantly in the coming years. The market, which was valued at USD 4.63 Bn in 2023, is anticipated to reach USD 6.45 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 3.37% during the forecast period of 2024 to 2033.

Gastroparesis Market

Report ID: PNPH1336 Industry: Pharma & Biotech

The Gastroparesis market is projected to grow significantly in the coming years. The market, which was valued at USD 8,352.13 Mn in 2023, is anticipated to reach USD 11,895.83 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 3.6% during the forecast period of 2024 to 2033.

Dry Age-Related Macular Degeneration Market

Report ID: PNPH1335 Industry: Pharma & Biotech

The Dry Age-Related Macular Degeneration market is projected to grow significantly in the coming years. The market, which was valued at USD 9.54 Bn in 2023, is anticipated to reach USD 20.9 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2033.

Dementia Market

Report ID: PNPH1334 Industry: Pharma & Biotech

The Dementia market is projected to grow significantly in the coming years. The market, which was valued at USD 15.48 Bn in 2023, is anticipated to reach USD 30 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast period of 2024 to 2033.

Chronic Wounds Market

Report ID: PNPH1333 Industry: Pharma & Biotech

The Chronic Wounds market is projected to grow significantly in the coming years. The market, which was valued at USD 13.3 Bn in 2023, is anticipated to reach USD 19.82 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 4.07% during the forecast period of 2024 to 2033.

Chronic Lower Back Pain Market

Report ID: PNPH1332 Industry: Pharma & Biotech

The Chronic Lower Back Pain market is projected to grow significantly in the coming years. The market, which was valued at USD 9,789.3 Mn in 2023, is anticipated to reach USD 17,458.2 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2024 to 2033.

Cervical Cancer Market

Report ID: PNPH1331 Industry: Pharma & Biotech

The Cervical Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 1.6 Bn in 2023, is anticipated to reach USD 5.7 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 13.7% during the forecast period of 2024 to 2033.

Car T Cell Therapy for Multiple Myeloma Market

Report ID: PNPH1330 Industry: Pharma & Biotech

The Car T Cell Therapy for Multiple Myeloma market is projected to grow significantly in the coming years. The market, which was valued at USD 720.3 Mn in 2023, is anticipated to reach USD 3999.64 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 18.7% during the forecast period of 2024 to 2033.

Brain Cancer Market

Report ID: PNPH1329 Industry: Pharma & Biotech

The Brain Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 1.8 Bn in 2023, is anticipated to reach USD 3.19 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.9% during the forecast period of 2024 to 2033.

Atrial Fibrillation Market

Report ID: PNPH1320 Industry: Pharma & Biotech

The Atrial Fibrillation market is projected to grow significantly in the coming years. The market, which was valued at USD 10.8 Bn in 2023, is anticipated to reach USD 19.3 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.0% during the forecast period of 2024 to 2033.

Spinal Cord Injury Epidemiology Market

Report ID: PNPH1319 Industry: Pharma & Biotech

The Spinal Cord Injury Epidemiology market is projected to grow significantly in the coming years. The market, which was valued at USD 7.2 Bn in 2023, is anticipated to reach USD 11.8 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.1% during the forecast period of 2024 to 2033.

Allergic Conjunctivitis Market

Report ID: PNPH1328 Industry: Pharma & Biotech

The Allergic Conjunctivitis market is projected to grow significantly in the coming years. The market, which was valued at USD 4,176.62 Mn in 2023, is anticipated to reach USD 7,409.43 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 5.9% during the forecast period of 2024 to 2033.

Spinal Muscular Atrophy Market

Report ID: PNPH1327 Industry: Pharma & Biotech

The Spinal Muscular Atrophy market is projected to grow significantly in the coming years. The market, which was valued at USD 1813.48 Mn in 2023, is anticipated to reach USD 6,321.38 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 13.3% during the forecast period of 2024 to 2033.

Prostate Cancer Market

Report ID: PNPH1326 Industry: Pharma & Biotech

The Prostate Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 10.92 Bn in 2023, is anticipated to reach USD 24.7 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2024 to 2033.

Pancreatic Cancer Market

Report ID: PNPH1325 Industry: Pharma & Biotech

The Pancreatic Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 2,125.57 Mn in 2023, is anticipated to reach USD 7,541.09 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2033.

Multiple Sclerosis Market

Report ID: PNPH1324 Industry: Pharma & Biotech

The Multiple Sclerosis market is projected to grow significantly in the coming years. The market, which was valued at USD 26.5 Bn in 2023, is anticipated to reach USD 38.1 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 3.7% during the forecast period of 2024 to 2033.

Multiple Myeloma Market

Report ID: PNPH1323 Industry: Pharma & Biotech

The Multiple Myeloma market is projected to grow significantly in the coming years. The market, which was valued at USD 25 Bn in 2023, is anticipated to reach USD 46.9 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2024 to 2033.

Epilepsy Market

Report ID: PNPH1322 Industry: Pharma & Biotech

The Epilepsy market is projected to grow significantly in the coming years. The market, which was valued at USD 2300.00 Mn in 2023, is anticipated to reach USD 4482.34 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 6.9% during the forecast period of 2024 to 2033.

Cystic Fibrosis Market

Report ID: PNPH1321 Industry: Pharma & Biotech

The Cystic Fibrosis market is projected to grow significantly in the coming years. The market, which was valued at USD 6.1 Bn in 2023, is anticipated to reach USD 17.3 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2024 to 2033.

Idiopathic Pulmonary Fibrosis Market

Report ID: PNPH1318 Industry: Pharma & Biotech

The Idiopathic Pulmonary Fibrosis market is projected to grow significantly in the coming years. The market, which was valued at USD 4 Bn in 2023, is anticipated to reach USD 7.4 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2024 to 2033.

Dry Eye Disease Market

Report ID: PNPH1317 Industry: Pharma & Biotech

The Dry Eye Disease market is projected to grow significantly in the coming years. The market, which was valued at USD 6.5 Bn in 2023, is anticipated to reach USD 13.2 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 7.4% during the forecast period of 2024 to 2033.

Antimicrobial Susceptibility Testing Market

Report ID: PNPH1316 Industry: Pharma & Biotech

The Antimicrobial Susceptibility Testing market is projected to grow significantly in the coming years. The market, which was valued at USD 3.8 Bn in 2023, is anticipated to reach USD 6.4 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2033.

Acute Ischemic Stroke (AIS) Market

Report ID: PNPH1315 Industry: Pharma & Biotech

The Acute Ischemic Stroke (AIS) market is projected to grow significantly in the coming years. The market, which was valued at USD 1481.4 Mn in 2023, is anticipated to reach USD 2833.46 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 6.7% during the forecast period of 2024 to 2033.

Herpes Labialis Market

Report ID: PNPH1314 Industry: Pharma & Biotech

The Herpes Labialis market is projected to grow significantly in the coming years. The market, which was valued at USD 1.13 Bn in 2023, is anticipated to reach USD 1.79 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2033.

HER-2 Positive Gastric Cancer Market

Report ID: PNPH1313 Industry: Pharma & Biotech

The HER-2 Positive Gastric Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 1261.8 Mn in 2023, is anticipated to reach USD 1779.8 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 3.5% during the forecast period of 2024 to 2033.

HER-2 Positive Early Breast Cancer Market

Report ID: PNPH1312 Industry: Pharma & Biotech

The HER-2 Positive Early Breast Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 10.8 Bn in 2023, is anticipated to reach USD 22.4 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2033.

Hepatitis B Virus (HBV) Infection Market

Report ID: PNPH1311 Industry: Pharma & Biotech

The Hepatitis B Virus (HBV) Infection market is projected to grow significantly in the coming years. The market, which was valued at USD 4.9 Bn in 2023, is anticipated to reach USD 7.11 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 3.8% during the forecast period of 2024 to 2033.

Hepatic Encephalopathy Market

Report ID: PNPH1310 Industry: Pharma & Biotech

The Hepatic Encephalopathy market is projected to grow significantly in the coming years. The market, which was valued at USD 1486.39 Mn in 2023, is anticipated to reach USD 2971.51 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2024 to 2033.

Glioblastoma Market

Report ID: PNPH1309 Industry: Pharma & Biotech

The Glioblastoma market is projected to grow significantly in the coming years. The market, which was valued at USD 2.65 Bn in 2023, is anticipated to reach USD 6.57 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024 to 2033.

Glaucoma Market

Report ID: PNPH1308 Industry: Pharma & Biotech

The Glaucoma market is projected to grow significantly in the coming years. The market, which was valued at USD 8.6 Bn in 2023, is anticipated to reach USD 13.48 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2024 to 2033.

Nuclear Medicine/ Radio-pharmaceuticals Market

Report ID: PNPH1307 Industry: Pharma & Biotech

The Nuclear Medicine/ Radio-pharmaceuticals market is projected to grow significantly in the coming years. The market, which was valued at USD 5.3 Bn in 2023, is anticipated to reach USD 15.5 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2024 to 2033.

Obesity Management Market

Report ID: PNPH1306 Industry: Pharma & Biotech

The Obesity Management market is projected to grow significantly in the coming years. The market, which was valued at USD 2095.6 Mn in 2023, is anticipated to reach USD 3479.09 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 5.2% during the forecast period of 2024 to 2033.

Liposome Drug Delivery Market

Report ID: PNPH1305 Industry: Pharma & Biotech

The Liposome Drug Delivery market is projected to grow significantly in the coming years. The market, which was valued at USD 4.50 Bn in 2023, is anticipated to reach USD 10.17 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2024 to 2033.

Laboratory Automation Market

Report ID: PNPH1304 Industry: Pharma & Biotech

The Laboratory Automation market is projected to grow significantly in the coming years. The market, which was valued at USD 5.3 Bn in 2023, is anticipated to reach USD 9.5 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2033.

High Potency API Market

Report ID: PNPH1303 Industry: Pharma & Biotech

The High Potency API market is projected to grow significantly in the coming years. The market, which was valued at USD 25.2 Bn in 2023, is anticipated to reach USD 59.9 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 10.1% during the forecast period of 2024 to 2033.

Orphan Drugs Market

Report ID: PNPH1302 Industry: Pharma & Biotech

The Orphan Drugs market is projected to grow significantly in the coming years. The market, which was valued at USD 1.5 Bn in 2023, is anticipated to reach USD 4.7 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 10.4% during the forecast period of 2024 to 2033.

Genetic Toxicity Testing Market

Report ID: PNPH1301 Industry: Pharma & Biotech

The Genetic Toxicity Testing market is projected to grow significantly in the coming years. The market, which was valued at USD 1.8 Bn in 2023, is anticipated to reach USD 4.75 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2033.

Fragment-based Drug Delivery Market

Report ID: PNPH1300 Industry: Pharma & Biotech

The Fragment-based Drug Delivery market is projected to grow significantly in the coming years. The market, which was valued at USD 1.1 Bn in 2023, is anticipated to reach USD 3.12 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2024 to 2033.

CRO (Contract Research Organization) Services Market

Report ID: PNPH1299 Industry: Pharma & Biotech

The CRO (Contract Research Organization) Services market is projected to grow significantly in the coming years. The market, which was valued at USD 75.5 Bn in 2023, is anticipated to reach USD 53.66 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 10.1% during the forecast period of 2024 to 2033.

Benign Breast Disease and Early Breast Cancer Market

Report ID: PNPH1298 Industry: Pharma & Biotech

The Benign Breast Disease and Early Breast Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 8500.0 Mn in 2023, is anticipated to reach USD 9864.6 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 1.5% during the forecast period of 2024 to 2033.

Antisense & RNAi Therapeutics Market

Report ID: PNPH1297 Industry: Pharma & Biotech

The Antisense & RNAi Therapeutics market is projected to grow significantly in the coming years. The market, which was valued at USD 4.12 Bn in 2023, is anticipated to reach USD 22.69 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 4.12% during the forecast period of 2024 to 2033.

Gastric Ulcers Market

Report ID: PNPH1296 Industry: Pharma & Biotech

The Gastric Ulcers market is projected to grow significantly in the coming years. The market, which was valued at USD 4.57 Bn in 2023, is anticipated to reach USD 6.96 bn by 2033, reflecting a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2024 to 2033.

Gastric Neuroendocrine Tumors Market

Report ID: PNPH1295 Industry: Pharma & Biotech

The Gastric Neuroendocrine Tumors market is projected to grow significantly in the coming years. The market, which was valued at USD 2689.87 Mn in 2023, is anticipated to reach USD 7300.53 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 10.5% during the forecast period of 2024 to 2033.

Filariasis Market

Report ID: PNPH1294 Industry: Pharma & Biotech

The Filariasis market is projected to grow significantly in the coming years. The market, which was valued at USD 10.96 Bn in 2023, is anticipated to reach USD 28.68 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 10.1% during the forecast period of 2024 to 2033.

Fibromyalgia Market

Report ID: PNPH1293 Industry: Pharma & Biotech

The Fibromyalgia market is projected to grow significantly in the coming years. The market, which was valued at USD 2.8 Bn Mn in 2023, is anticipated to reach USD 5.4 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2033.

Familial Chylomicronemia Syndrome Market

Report ID: PNPH1292 Industry: Pharma & Biotech

The Familial Chylomicronemia Syndrome market is projected to grow significantly in the coming years. The market, which was valued at USD 17 Mn in 2023, is anticipated to reach USD 35.3 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 15.3% during the forecast period of 2024 to 2033.

Fallopian Tube Cancer Market

Report ID: PNPH1291 Industry: Pharma & Biotech

The Fallopian Tube Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 3.5 Bn in 2023, is anticipated to reach USD 14.5 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 15.3% during the forecast period of 2024 to 2033.

Eosinophilia Market

Report ID: PNPH1290 Industry: Pharma & Biotech

The Eosinophilia market is projected to grow significantly in the coming years. The market, which was valued at USD 410 Mn in 2023, is anticipated to reach USD 734.25 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 6.0% during the forecast period of 2024 to 2033.

Drug Discovery Services Market

Report ID: PNPH1289 Industry: Pharma & Biotech

The Drug Discovery Services market is projected to grow significantly in the coming years. The market, which was valued at USD 20.5 Bn in 2023, is anticipated to reach USD 53.66 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 10.1% during the forecast period of 2024 to 2033.

Developmental and Epileptic Encephalopathies (DEE) Market

Report ID: PNPH1288 Industry: Pharma & Biotech

The Developmental and Epileptic Encephalopathies (DEE) market is projected to grow significantly in the coming years. The market, which was valued at USD 7 Bn in 2023, is anticipated to reach USD 11.6 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.2% during the forecast period of 2024 to 2033.

Continuous Manufacturing Market

Report ID: PNPH1287 Industry: Pharma & Biotech

The Continuous Manufacturing market is projected to grow significantly in the coming years. The market, which was valued at USD 430.2 Mn in 2023, is anticipated to reach USD 972.7 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2024 to 2033.

Chronic Pain Market

Report ID: PNPH1286 Industry: Pharma & Biotech

The Chronic Pain market is projected to grow significantly in the coming years. The market, which was valued at USD 71.6 Bn in 2023, is anticipated to reach USD 138.39 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2033.

Corneal Endothelial Dystrophy Market

Report ID: PNPH1285 Industry: Pharma & Biotech

The Corneal Endothelial Dystrophy market is projected to grow significantly in the coming years. The market, which was valued at USD 170 Bn in 2023, is anticipated to reach USD 350.38 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2024 to 2033.

Car T-Cell Therapy for Acute Lymphoblastic Leukemia Market

Report ID: PNPH1284 Industry: Pharma & Biotech

The Car T-Cell Therapy for Acute Lymphoblastic Leukemia market is projected to grow significantly in the coming years. The market, which was valued at USD 2.8 Bn in 2023, is anticipated to reach USD 28.6 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 26.2% during the forecast period of 2024 to 2033.

Cancer Vaccines Market

Report ID: PNPH1283 Industry: Pharma & Biotech

The Cancer Vaccines market is projected to grow significantly in the coming years. The market, which was valued at USD 9.50 Bn in 2023, is anticipated to reach USD 18.98 Bn Mn by 2033, reflecting a compound annual growth rate (CAGR) of 5.1% during the forecast period of 2024 to 2033.

Community Acquired Bacterial Pneumonia (CABP) Market

Report ID: PNPH1282 Industry: Pharma & Biotech

The Community Acquired Bacterial Pneumonia (CABP) market is projected to grow significantly in the coming years. The market, which was valued at USD 5 Bn in 2023, is anticipated to reach USD 8.3 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 5.2% during the forecast period of 2024 to 2033.

Bronchiolitis Obliterans Syndrome Market

Report ID: PNPH1281 Industry: Pharma & Biotech

The Bronchiolitis Obliterans Syndrome market is projected to grow significantly in the coming years. The market, which was valued at USD 60 Mn in 2023, is anticipated to reach USD 98.67 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 5.1% during the forecast period of 2024 to 2033.

Biosimilars Market

Report ID: PNPH1280 Industry: Pharma & Biotech Therapy Area: Others

The Biosimilars market is projected to grow significantly in the coming years. The market, which was valued at USD 29.1 Bn in 2023, is anticipated to reach USD 122.75 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 15.5% during the forecast period of 2024 to 2033.

Biologics Contract Manufacturing Market

Report ID: PNPH1279 Industry: Pharma & Biotech Therapy Area: Others

The Biologics Contract Manufacturing market is projected to grow significantly in the coming years. The market, which was valued at USD 16.4 Bn in 2023, is anticipated to reach USD 36.40 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 8.3% during the forecast period of 2024 to 2033.

Acute Myeloid Leukemia Market

Report ID: PNPH1278 Industry: Pharma & Biotech Therapy Area: Others

The Acute Myeloid Leukemia market is projected to grow significantly in the coming years. The market, which was valued at USD 1.50 Bn in 2023, is anticipated to reach USD 3.25 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2033.

Acute Heart Failure (AHF) Market

Report ID: PNPH1277 Industry: Pharma & Biotech Therapy Area: Others

The Acute Heart Failure (AHF) market is projected to grow significantly in the coming years. The market, which was valued at USD 270.6 Mn in 2023, is anticipated to reach USD 2622.8 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 25.5% during the forecast period of 2024 to 2033.

Endoscopic Equipment Market

Report ID: PNPH1276 Industry: Pharma & Biotech Therapy Area: Musculoskeletal Disorders

The Endoscopic Equipment market is projected to grow significantly in the coming years. The market, which was valued at USD 30 Bn in 2023, is anticipated to reach USD 59 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2024 to 2033.

Clear Cell HER2 Non-Small Cell Lung Cancer Market

Report ID: PNPH1275 Industry: Pharma & Biotech Therapy Area: Others

The Clear Cell HER2 Non-Small Cell Lung Cancer market is projected to grow significantly in the coming years. The market, which was valued at USD 5.2 Bn in 2023, is anticipated to reach USD 9.4 Bn by 2033, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast period of 2024 to 2033.

Global Urothelial Carcinoma Treatment Market

Report ID: PNPH1272 Industry: Pharma & Biotech Therapy Area: Oncology

According to industry analyst Pharmanucleus, the global urothelial carcinoma treatment market is expected to witness robust growth during the forecast period from 2023 to 2030. The projected compound annual growth rate (CAGR) for the market is estimated to be around 20%. In 2022, the market was valued at USD 0.81 billion, and it is predicted to reach USD 3.48 billion by 2030.

Global Tumor Infiltrating Lymphocytes Market

Report ID: PNPH1270 Industry: Pharma & Biotech Therapy Area: Oncology

According to Pharmanucleus, the tumor infiltrating lymphocytes (TILs) market is projected to grow significantly in the coming years. The market, which was valued at USD 9.17 billion in 2022, is anticipated to reach USD 25.5 billion by 2030, reflecting a compound annual growth rate (CAGR) of 12.00% during the forecast period of 2023 to 2030.

Global Polycythemia Vera Market

Report ID: PNPH1269 Industry: Pharma & Biotech Therapy Area: Hematological Disorders

The overall market size of Polycythemia Vera in the United States is expected to expand at a CAGR of 14% during the research period (2023-2030).PV is a condition that causes an increase in the amount of red blood cells in the bloodstream from a variety of factors. Itching, headache, dizziness, fatigue, blind spots, leukaemia, and, in rare cases, a heart attack induced by an atypical thrombotic event are all visible signs.

Global Pediatric Brain Tumor Market

Report ID: PNPH1268 Industry: Pharma & Biotech Therapy Area: Oncology

The pediatric brain tumor market is growing at a CAGR of 6.8% over the forecast period and is expected to reach USD 1,843.7 million by 2022-2030. Pediatric brain tumor is an uncontrolled or abnormal growth of normal cells in the brain in children. Brain tumors are mainly of two types, cancerous (malignant) and non-cancerous (benign).

Global Ovarian Cancer Market

Report ID: PNPH1267 Industry: Pharma & Biotech Therapy Area: Oncology

The global ovarian cancer market is expected to witness significant growth over the forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of this market. Multiple therapeutic landscapes and family history of ovarian cancer are seen as positive indicators of demand for new ovarian cancer drugs.

Neuroendocrine Tumor Market

Report ID: PNPH1265 Industry: Pharma & Biotech Therapy Area: Oncology

The Neuroendocrine Tumor Market is expected to witness market growth during the forecast period of 2023 to 2030. Pharmanucleusanalyzes that the market is growing with a CAGR of 10.4% during the forecast period of 2023 to 2030 and is expected to to reach USD 5,300.53 million by 2030.

Neuroendocrine Tumor Treatment Market

Report ID: PNPH1264 Industry: Pharma & Biotech Therapy Area: Oncology

The Global Neuroendocrine Carcinoma Treatment market is expected to reach US$ 1.7 billion by 2022, with a CAGR of 8.0% indicating favourable market expansion throughout the projected period.This report provides a comprehensive analysis of the global neuroendocrine tumor treatment market.

Global Infection Control Market

Report ID: PNPH1262 Industry: Pharma & Biotech Therapy Area: Infectious Disease

The global infection control market in terms of revenue was estimated to be worth $50.0 billion in 2023 and is poised to reach $58.3 billion by 2030, growing at a CAGR of 3.1% from 2023 to 2030.The new research study consists of an analysis of market industry trends. The new research study includes industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behavior in the market.

HPV16 Anogenital Cancer Market

Report ID: PNPH1260 Industry: Pharma & Biotech Therapy Area: Oncology

The HPV16 anogenital cancers market is projected to experience a high compound annual growth rate CAGR~1% from 2023 to 2030. This specialized sector of oncology focuses on the diagnosis, treatment, and management of anogenital cancers caused by HPV16, a high-risk strain of the human papillomavirus.

Global Hodgkin’s Lymphoma Market

Report ID: PNPH1258 Industry: Pharma & Biotech Therapy Area: Oncology

Hodgkin's lymphoma (HL) is a specific type of cancer affecting the lymphatic system, characterized by the presence of Reed-Sternberg cells in the lymph nodes. These abnormal cells play a crucial role in HL diagnosis. The HL market encompasses various products and services related to the diagnosis, treatment, and management of this disease.

Global HLA Typing Market

Report ID: PNPH1257 Industry: Pharma & Biotech Therapy Area: Immunological Disorder

The global HLA typing market in terms of revenue was estimated to be worth $1.4 billion in 2022 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 6.5% from 2022 to 2028. The new research study includes a market industry trend analysis. The new study report covers industry trends, price analysis, patent analysis, conference and webinar materials, important stakeholders, and market purchasing behaviour.

Global Gastric Cancer Market

Report ID: PNPH1256 Industry: Pharma & Biotech Therapy Area: Oncology

Pharmanucleus, a research organization, has conducted an analysis on the projected growth rate of the global gastric cancer market for the forecast period of 2023-2030. According to their findings, the market is expected to experience a Compound Annual Growth Rate (CAGR) of approximately 16% during this period.

Fuchs’ Endothelial Corneal Dystrophy Market

Report ID: PNPH1255 Industry: Pharma & Biotech Therapy Area: Ophthalmological Disorder

The Fuchs Endothelial Corneal Dystrophy Market is predicted to grow throughout the forecast period of 2023-2030. In order to assume growth at a CAGR of 8.40% throughout the previously predicted period, Pharmanucleus undertakes a market study.

Global FGFR Positive Gastroesophageal Cancer Market

Report ID: PNPH1254 Industry: Pharma & Biotech Therapy Area: Oncology

The global FGFR Positive Gastroesophageal Cancer Market size was valued at $YY million in 2022 and is projected to reach $YY million by 2030, growing at a high CAGR during the forecast period from 2023 to 2030.The FGFR (fibroblast growth factor receptor) positive gastroesophageal cancer market encompasses the pharmaceutical and biotechnology products specifically designed to target FGFR gene alterations in patients with gastroesophageal cancer.

Global ESR1 Mutation Metastatic Breast Cancer Diagnostics Market

Report ID: PNPH1253 Industry: Pharma & Biotech Therapy Area: Oncology

The global ESR1 Mutation Metastatic Breast Cancer Diagnostics Market generated a Market Value of US$58.70 Million in 2022 and is expected to accumulate a Market Value of US$185 Million by registering a CAGR of 11% during the forecast period 2023 to 2030.

Epithelioid Sarcoma Treatment Market

Report ID: PNPH1252 Industry: Pharma & Biotech Therapy Area: Oncology

The global sarcoma market size was valued at $YY million in 2022 and is projected to reach $YY million by 2030, growing at a CAGR of 8.3% from 2023 to 2030.Epithelioid sarcoma is a rare and aggressive soft tissue sarcoma that primarily affects young adults. The market for epithelioid sarcoma treatment is relatively small due to its low incidence, presenting limited commercial opportunities for pharmaceutical companies.

Epithelial Ovarian Cancer Market

Report ID: PNPH1251 Industry: Pharma & Biotech Therapy Area: Oncology

The epithelial ovarian cancer market is growing steadily owing to the rising incidence of this malignancy. Epithelial ovarian cancer, the most common type of ovarian cancer, poses significant health risks to women worldwide. The market is driven by advances in treatment options such as surgery, chemotherapy, targeted therapy and immunotherapy which improve patient outcomes.

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market

Report ID: PNPH1250 Industry: Pharma & Biotech Therapy Area: Oncology

The Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market is a rapidly evolving sector within the field of lung cancer therapeutics. EGFR-NSCLC is a distinct subtype of non-small cell lung cancer characterized by specific genetic mutations affecting the EGFR gene.

Global Endometrial Cancer Market

Report ID: PNPH1249 Industry: Pharma & Biotech Therapy Area: Oncology

The Endometrial Cancer Market is anticipated to reach USD 22,187.69 Million by 2030 at 4.20% CAGR during the forecast period 2023-2030. Endometrial cancer, commonly known as uterine cancer, is the abnormal development of endometrium cells in the uterus. Women with abnormal vaginal bleeding are diagnosed with endometrial cancer at an early stage.

Global Diffuse Large B-cell Lymphoma Therapeutics Market

Report ID: PNPH1248 Industry: Pharma & Biotech Therapy Area: Hematological Disorders

The Diffuse Large B-cell Lymphoma (DLBCL) Therapeutics Market refers to the market for drugs and therapies used in the treatment of diffuse large B-cell lymphoma, which is a type of aggressive non-Hodgkin lymphoma. The market size of DLBCL therapeutics was valued at USD 4,107.50 million in 2021.

Global Diabetic Neuropathy Market

Report ID: PNPH1247 Industry: Pharma & Biotech Therapy Area: Endocrinological Disorder

Pharmanucleusanalyzes a growth rate of the diabetic neuropathy market over the forecast period 2023-2030. The expected CAGR of the diabetic neuropathy market tends to be around 6.9% during the mentioned forecast period. The market was valued at USD 3876.6 Million in 2022, and it will reach USD 6611.08 Million by 2030.

Global Dengue Vaccine Market

Report ID: PNPH1246 Industry: Pharma & Biotech Therapy Area: Vaccines

Pharmanucleusanalyzes a growth rate of the Dengue Vaccine market over the forecast period 2023-2030. The expected CAGR of the dengue fever vaccine market tends to be around 11.7% during the mentioned forecast period. The market was valued at USD 0.53 Billion in 2022 and it will reach USD 1.28 Billion by 2030.

Global Dementia Drugs Market

Report ID: PNPH1245 Industry: Pharma & Biotech Therapy Area: Neurological Disorder

The Dementia Drugs Market size was valued at $8.7 billion in 2023, and is projected to reach $19.7 billion by 2030, growing at a CAGR of 8.5% from 2022 to 2030.Dementia causes a decline in mental function from a previously higher level that is severe enough to interfere with daily life.

Global Crohn’s Disease Market

Report ID: PNPH1244 Industry: Pharma & Biotech Therapy Area: Others

Crohn's Disease Market size was valued at USD 11.1 Billion in 2022 and is projected to grow from USD 11.5 Billion in 2023 to USD 14.3 Billion by 2030, growing at a compound annual growth rate (CAGR ) by 3.70% over the forecast period (2023 - 2030). One of the major market drivers fueling the expansion of the market is the rising prevalence of Crohn's disease due to changes in people's lifestyles.

Global Coronary Microvascular Dysfunction Market

Report ID: PNPH1243 Industry: Pharma & Biotech Therapy Area: Others

Coronary microvascular dysfunction (CMD) refers to a condition characterized by abnormalities in the small blood vessels of the heart, resulting in impaired blood flow to the heart muscle. CMD is a significant health problem because it can lead to chest pain, heart attacks, and heart failure.

Global Congestive Heart Failure Market

Report ID: PNPH1242 Industry: Pharma & Biotech Therapy Area: Others

Pharmanucleusanalyzes a growth rate of the global congestive heart failure market over the forecast period 2023-2030. The expected CAGR of the global congestive heart failure market tends to be around 7.0% during the mentioned forecast period. The market was valued at USD 21 Billion in 2021, and it will reach USD 36.08 Billion by 2030.

Global Complex Regional Pain Syndrome (CRPS) Market

Report ID: PNPH1241 Industry: Pharma & Biotech Therapy Area: Neurological Disorder

The global market for complex regional pain syndrome (CRPS) is estimated to be worth US$ 101.9 Million in 2023, rising to US$ 126.7 Million by 2030. During the projection period of 2023 to 2030, the market is forecast to grow at a CAGR of 2.2%.The increase in the number of people suffering from the complex regional pain syndrome (CRPS), chronic pain and back failure syndrome is one of the major reasons for the development of the market.

Global Colorectal Cancer Market

Report ID: PNPH1240 Industry: Pharma & Biotech Therapy Area: Oncology

The colorectal cancer market is expected to grow from US$ 18,619.3 million in 2023 to US$ 24,078.5 million by 2030; it is expected to grow at a CAGR of 3.3% from 2023 to 2030.Factors such as increasing prevalence of colorectal cancer, product launches, and benefits offered by generic drugs are driving the growth of the global colorectal cancer market.

Global Clear Cell Ovarian Cancer Market

Report ID: PNPH1239 Industry: Pharma & Biotech Therapy Area: Oncology

Clear Cell Ovarian CancerMarket size was valued at USD 1.57 billion in 2021 and is poised to grow from USD 1.77 billion in 2022 to USD 9.67 billion by 2030, growing at a CAGR of 23.7% in the forecast period (2023-2030).Clear cell ovarian cancer is a rare subtype of ovarian cancer characterized by the presence of clear cells in the tumor. It accounts for approximately 5-10% of all ovarian cancer cases.

Global Chronic Rhinosinusitis Market

Report ID: PNPH1238 Industry: Pharma & Biotech Therapy Area: Ear Nose Throat Disorders

Global Chronic Rhinosinusitis Market was valued at USD 2,132.5 Million in 2019 and is projected to reach USD 3,508.0 Million by 2030, growing at a CAGR of 7.4%. Rising incidence of inflammation of nasal passage mucosa, growing prevalence of chronic asthma and paranasal sinus cases are likely to fuel the growth prospects of the chronic rhinosinusitis market over the forecast period .

Global Chronic Myeloid Leukemia (CML) Treatment Market

Report ID: PNPH1237 Industry: Pharma & Biotech Therapy Area: Hematological Disorders

The chronic myeloid leukemia (CML) treatment market is characterized by the presence of several effective therapies and ongoing research and development efforts. CML is a type of blood cancer caused by the abnormal growth of white blood cells. Targeted therapies, such as tyrosine kinase inhibitors (TKIs), have revolutionized the treatment landscape by effectively managing the disease and improving patient outcomes.

Global Chronic Myelogenous Leukaemia Treatment Market

Report ID: PNPH1236 Industry: Pharma & Biotech Therapy Area: Hematological Disorders

The global Chronic Myelogenous Leukaemia Treatment Market is expected to exhibit a CAGR of 6.0% during the forecast period (2023-2030) The Chronic Myelogenous Leukemia (CML) treatment market has witnessed significant advancements and growth over the years. CML is a type of blood cancer that affects the bone marrow and leads to the overproduction of abnormal white blood cells.

Global Chronic lymphocytic leukemia Market

Report ID: PNPH1235 Industry: Pharma & Biotech Therapy Area: Hematological Disorders

Chronic lymphocytic leukemia Market is estimated to reach a CAGR of 6.01% over the forecast by 2023 – 2030.The chronic lymphocytic leukemia (CLL) market is a dynamic and evolving landscape characterized by continuous research and development activities. CLL is a type of blood cancer that affects the lymphocytes, a type of white blood cell.

Global Chemotherapy-Induced Peripheral Neuropathy Market

Report ID: PNPH1234 Industry: Pharma & Biotech Therapy Area: Oncology

Chemotherapy Induced Peripheral Neuropathy Market is expected to reach US$1,174.26 million by 2030, from US$813.48 million in 2023; it is expected to register a CAGR of 5.4% from 2023 to 2030.Chemotherapy-induced peripheral neuropathy (CIPN) is a prevalent side effect that occurs as a result of treatment with antineoplastic agents.

Global Bruton Tyrosine Kinase (BTK) Inhibitors Market

Report ID: PNPH1233 Industry: Pharma & Biotech Therapy Area: Hematological Disorders

The market for Bruton tyrosine kinase (BTK) inhibitors is anticipated to experience significant growth in the coming years. BTK is a critical component of the B cell receptor (BCR) signaling pathway, and its dysregulation has been implicated in various B-cell lymphomas, including chronic lymphocytic leukemia (CLL).

Global BRAF Mutant Metastatic Melanoma Market

Report ID: PNPH1232 Industry: Pharma & Biotech Therapy Area: Oncology

The BRAF Mutant Metastatic Melanoma Market is projected to reach a high CAGR over the forecast period 2023 - 2030.The market for BRAF mutant metastatic melanoma treatment is highly competitive and dynamic. BRAF mutations are found in a significant proportion of melanoma patients, making it a crucial target for therapy.

Global Bone Metastasis Market

Report ID: PNPH1231 Industry: Pharma & Biotech Therapy Area: Oncology

The global bone metastasis market size was significantly robust in 2021 and is expected to register a rapid revenue CAGR over the forecast period. Bone metastasis market revenue growth is primarily driven by the rise in cancer incidences globally.Bone metastasis refers to the spread of cancer from its original location to the bones. This process, known as metastasis, is common in various types of cancer, with breast and prostate cancer exhibiting a higher propensity for bone metastasis.

Global Bile Duct Cancer Market

Report ID: PNPH1230 Industry: Pharma & Biotech Therapy Area: Oncology

The Bile Duct Cancer Market is anticipated to reach USD 198.4 Million by 2030 at 8.60% CAGR during the forecast period 2023-2030. Cholangiocarcinoma is a kind of cancer in which epithelial cells are altered, suggesting the growth of bile duct epithelial cells. Cancer's basic aetiology is unclear.

Global Adenoid Cystic Carcinoma Market

Report ID: PNPH1229 Industry: Pharma & Biotech Therapy Area: Oncology

Adenoid cystic carcinoma (ACC) is a rare form of cancer that commonly affects the salivary glands and other secretory glands. The ACC market is characterized by limited treatment options and a lack of targeted therapies due to its complex biology. However, ongoing research and development efforts are focused on identifying novel treatment strategies, including targeted therapies and immunotherapies, to improve patient outcomes.

Global Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Therapeutics Market

Report ID: PNPH1228 Industry: Pharma & Biotech Therapy Area: Oncology

Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Therapeutics MarketInsights The Acute Lymphoid/Lymphoblastic Leukemia (ALL) Therapeutics Market is expected to experience market growth during the forecast period of 2023 to 2030. Pharmanucleusanalyzes that the market is expected to grow at a CAGR of 5.25% during the above-mentioned forecast period. Rising prevalence of acute lymphoid/lymphoblastic leukemia (ALL) is driving the market for acute lymphoid/lymphoblastic leukemia (ALL) treatments.

Global Urinalysis Market

Report ID: PNPH1226 Industry: Pharma & Biotech Therapy Area: Urology

The global urinalysis market in terms of revenue was estimated to be worth $3.9 billion in 2023 and is poised to reach $5.7 billion by 2030, growing at a CAGR of 8.1% from 2023 to 2030. The new research study consists of an analysis of market industry trends.

Global Protein A Resin Market

Report ID: PNPH1219 Industry: Pharma & Biotech Therapy Area: Others

The global protein A resin market in terms of revenue was estimated to be worth $1.2 billion in 2023 and is poised to reach $2.1 billion by 2030, growing at a CAGR of 9.8% from 2023 to 2030The new research study includes a market industry trend analysis. The new study report covers industry trends, price analysis, patent analysis, conference and webinar materials, important stakeholders, and market purchasing behaviour.

Global Nuclear Medicine Market

Report ID: PNPH1213 Industry: Pharma & Biotech Therapy Area: Oncology

The global nuclear medicine market in terms of revenue was estimated to be worth $5.5 billion in 2023 and is poised to reach $9.4 billion by 2030, growing at a CAGR of 11.3% from 2023 to 2030. The new research study is an examination of market industry trends. Industry trends, price analysis, patent analysis, conference and webinar materials, important players, and market buying behaviour are all included in the new research report.

Global Exophthalmos Market

Report ID: PNPH1209 Industry: Pharma & Biotech Therapy Area: Ophthalmological Disorder

The Exophthalmos Market report, published by Pharmanucleus, provides a comprehensive analysis of the Exophthalmos condition, including its historical and forecasted epidemiology, as well as market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. The report covers current treatment practices, emerging drugs, market share of individual therapies, and the market size from 2023 to 2030, segmented by major markets.

Global Ewing Sarcoma Market

Report ID: PNPH1208 Industry: Pharma & Biotech Therapy Area: Oncology

The Ewing sarcoma market is estimated to increase at a CAGR of 6.30% between 2023 and 2030. The growing prevalence of Ewing sarcoma, improved awareness of the condition, and the discovery of novel treatment options are driving the market. Ewing sarcoma is a rare kind of soft tissue and bone cancer. It is most commonly diagnosed in children and teens, with a median age of 15 years old upon diagnosis.

Global Cold chain products Market

Report ID: PNPH1200 Industry: Pharma & Biotech Therapy Area: Others

It is estimated that the global cold chain market will grow to over US$278.2 billion in 2023 and reach over US$428.4 billion by the end of 2030, with GR 9.0 growth between 2023 and 2030. The globalisation of trade has boosted cross-border goods transit.

Global Chronic Pancreatitis Market

Report ID: PNPH1199 Industry: Pharma & Biotech Therapy Area: Nephrological Disorder

The chronic pancreatitis market is expected to grow at a CAGR of 5.70% during the forecast period of 2023 to 2030. The growth of the market is attributed to the rising prevalence of pancreatic disorders globally, increasing incidence of alcohol-induced pancreatitis, and growing demand for minimally invasive surgical procedures.

Global Chronic Lymphocytic Leukemia Treatment Market

Report ID: PNPH1198 Industry: Pharma & Biotech Therapy Area: Hematological Disorders

The market size for treatments for chronic lymphocytic leukaemia was estimated at USD 4.9 billion in 2023. The market for treating chronic lymphocytic leukaemia is anticipated to increase from USD 5.3 billion in 2023 to USD 8.68 billion in 2030, with a compound annual growth rate (CAGR) of 8.52% over the five-year forecast period (2023–2030).

Global Chronic Bronchitis Market

Report ID: PNPH1197 Industry: Pharma & Biotech Therapy Area: Respiratory disorders

The global chronic bronchitis market is expected to grow considerably over the projected period. The global increase in allergic reactions, as well as the growth of emerging markets, are moving this industry ahead. The increased prevalence of asthma and COPD, both of which cause severe coughing, is driving the chronic bronchitis market.

Global Bladder Cancer Market

Report ID: PNPH1196 Industry: Pharma & Biotech Therapy Area: Oncology

Bladder Cancer Market Size was valued at USD 5.5 Billion in 2022. The Bladder Cancer market industry is projected to grow from USD 5.8 Billion in 2023 to USD 8.2 Billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.60% during the forecast period (2023 - 2030).

Global autoimmune Hepatitis Market

Report ID: PNPH1195 Industry: Pharma & Biotech Therapy Area: Immunological Disorder

Global Autoimmune Hepatitis Market, By Type (Type 1, Type 2), Treatment (Medications, Liver Transplant, Others), Diagnosis (Liver Biopsy, Blood Tests, Imaging Tests, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030

Global Asthma Treatment Market

Report ID: PNPH1194 Industry: Pharma & Biotech Therapy Area: Respiratory disorders

Asthma Treatment Market is segmented By Treatment (Long-Term Control Medications,Quick-Relief Medications,Route Of Administration (Injectable,Oral,Inhaled), By Distribution Channel (Hospital Pharmacies,Retail Pharmacies & Drug Stores,Online Pharmacies), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa) – Share, Size, Outlook, And Opportunity Analysis, 2023-2030.

Global Antimicrobial Susceptibility Market

Report ID: PNPH1193 Industry: Pharma & Biotech Therapy Area: Infectious Disease

The worldwide antimicrobial susceptibility testing market is expected to increase at a 5.5% CAGR from 2022 to 2027, from an anticipated value of US$3.6 billion in 2022 to US$4.7 billion in 2027. The Antimicrobial Susceptibility Testing (AST) Technology Market is expanding due to factors such as rising infectious illness prevalence, increased antibiotic resistance, and favourable government measures to minimise infectious disease burden.

Global Acute Pancreatitis Market

Report ID: PNPH1191 Industry: Pharma & Biotech Therapy Area: Others

The Acute Pancreatitis Market Size was valued at USD 5.5 billion in 2023 and is projected to grow from USD 5.8 Billion in 2023 to USD 8.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.90% during the forecast period (2023 - 2030). The major market driver fueling the expansion is the increased prevalence of gastrointestinal issues.

Acute Ocular Pain Market

Report ID: PNPH1189 Industry: Pharma & Biotech Therapy Area: Ophthalmological Disorder

The Acute Ocular Pain market is projected to grow significantly in the coming years. The market, which was valued at USD 195.2 Mn in 2023, is anticipated to reach USD 270.07 Mn by 2033, reflecting a compound annual growth rate (CAGR) of 3.3% during the forecast period of 2024 to 2033.

Global Acute Ischemic Stroke Market

Report ID: PNPH1186 Industry: Pharma & Biotech Therapy Area: Others

The Global Acute Ischemic Stroke (AIS) Market is estimated at USD 8,517.0 Million in 2023 and is projected to reach USD 11,185.3 Million by 2030, growing at a CAGR of 4.0% over the forecast period (2023-2030). Acute ischemic stroke (AIS) occurs when blood flow in a cerebral artery is blocked by a clot, which is a thickened mass of blood. Clots are classified as either thrombotic or embolic depending on where they form in the body.

Global Acute Coronary Syndrome Market

Report ID: PNPH1185 Industry: Pharma & Biotech Therapy Area: Others

Between 2023 and 2030, the Acute Coronary Syndrome Market is expected to grow significantly. The market will grow at a CAGR of 5.2% from 2023 to 2030, to reach USD 14,810.38 million by 2030, according to Pharmanucleus. An increase in the incidence of chronic diseases such as coronary heart disease, ischemic heart disease, and vascular disease, growing geriatric population, and diverse product offering by market players are the major drivers for the growth of the coronary syndrome market acute.

Global Osteoarthritis Market

Report ID: PNPH1183 Industry: Pharma & Biotech Therapy Area: Bone & Joint disorders

In 2023, the worldwide osteoarthritis market was valued at USD 7.40 billion and is predicted to increase at an 8.5% CAGR during the forecast period 2023-2030. Both the introduction of analgesic drugs and the development of imaging diagnostics based on radiographic characteristics are stimulating market growth. Increased expenditure on healthcare infrastructure and expanding investments in research and development (R&D) efforts to bring novel diagnostics and biomarkers are also driving the market.

Global Opioid Use Disorder Market

Report ID: PNPH1182 Industry: Pharma & Biotech Therapy Area: Neurological Disorder

The global Opioid Use Disorder (OUD) Market size was valued at USD 2.88 billion in 2023 and is projected to grow from USD 3.11 billion in 2022 to USD 5.64 billion by 2030, exhibiting a CAGR of 8.9% during the forecast period. Based on our analysis, the global market exhibited a decline of -10.1% in 2020 as compared to 2019. The global COVID-19 pandemic has been unprecedented and staggering, with opioid use disorder experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels.

Global Neuropathic Pain Market

Report ID: PNPH1181 Industry: Pharma & Biotech Therapy Area: Neurological Disorder

Global Neuropathic Pain Market From 2023 to 2030, the worldwide neuropathic pain market is predicted to increase at a CAGR of 9.2%. The market is being pushed by the rising prevalence of chronic pain and neuropathic pain syndromes linked to a variety of illnesses. Neuropathic pain is caused by a somatosensory system lesion or illness and affects 7-10% of the general population. Multiple causes of neuropathic pain have been identified, and its prevalence is expected to rise due to an ageing global population, an increase in diabetes mellitus, and improved cancer survival following treatment.

Global CTLA-4 Therapies Market

Report ID: PNPH1178 Industry: Pharma & Biotech Therapy Area: Oncology

The global CTLA-4 Therapies market is expected to reach USD 1384.4 million by 2030, at a CAGR of 7.1% during the forecast period 2022 to 2030. The modulation of cell motility and/or PI3 kinase signaling may also be other ways that CTLA-4 works. Early multiphoton microscopy investigations to observe T-cell movement in healthy lymph nodes seemed to support the

Cancer Supportive Care Drugs Market

Report ID: PNPH1177 Industry: Pharma & Biotech Therapy Area: Oncology

Cancer supportive care also known as palliative care is focused on relieving patients from the side effects of cancer therapies. In cancer palliative care, supportive drugs are used to lessen the side effects of cancer treatments. In many cases, cancer treatments need to be stopped or the dose needs to be lowered due to various reasons such as low blood cell counts. In such cases, supportive drugs such as CSFs enable patients to continue with cancer treatments as well as in other cases, it also allows higher doses of cancer therapies. 

Global Bleeding Disorders Treatment Market

Report ID: PNPH1176 Industry: Pharma & Biotech Therapy Area: Hematological Disorders

The bleeding disorders treatment was valued at USD 12.8 billion in 2021 and is projected to reach USD 18.6 billion by 2027, with a CAGR of 7.6% over the forecast period 2022-2027. The growth could be attributed to the return of demand to pre-pandemic levels, increasing authorization of novel & innovative medicines, extensive research, disease prevalence, and immunotherapies. 

Global Anticoccidial Drugs Market

Report ID: PNPH1174 Industry: Pharma & Biotech Therapy Area: Infectious Disease

In April 2019, Creative Diagnostics developed anticoccidial drug assay products to test anticoccidial drug residues in animals. This advancement and awareness of anticoccidial drugs will impact the trend of the anticoccidial drugs market. Growing awareness of animal health and zootonic diseases is expected to increase acceptance of anticoccidial drugs. The rising carnivorous population and reliance on bovine products is expected to be a driving factor for the growth of the anticoccidial drugs market. Additionally, the increase in research and development of veterinary drugs is expected to provide growth opportunities for anticoccidial drugs. 

Global Viral Vector Gene Delivery Market

Report ID: PNPH1171 Industry: Pharma & Biotech Therapy Area: Others

Viral vector is the most sought-after way to transfer genes to specific cell types or tissues and manipulate them to express therapeutic genes. Currently, there are several types of viruses, such as adenovirus, adeno associated virus, baculovirus and retrovirus, which are being investigated in order to deliver the genes to required cells. This process can provide permanent as well as transient transgene expression.

Short Bowel Syndrome Market

Report ID: PNPH1169 Industry: Pharma & Biotech Therapy Area: Gastrointestinal Disorders

Short Bowel Syndrome (SBS) is a group of problems related to poor absorption of nutrients. The main cause of SBS is surgery to remove a portion of the small intestine. This surgery can treat intestinal diseases, injuries, and birth defects. Some people are born with an abnormally short small intestine, significant damage, and poor motility, which can cause short bowel syndrome. Presently, there is no cure for SBS and the treatment is targeted toward symptoms. In a few cases, SBS can be life-threatening but usually, the disease can be managed through effective medication.

Prostate Cancer Therapeutics Market

Report ID: PNPH1168 Industry: Pharma & Biotech Therapy Area: Oncology

When cells in the prostate gland begin to develop unnaturally and uncontrolled, it is called prostate cancer. The prostate is a gland found solely in males that produces some of the fluid found in sperm. Surgery, radiation, hormone therapy, chemotherapy, and other treatments are available for prostate cancer. Prostate cancer therapy is determined on the stage of the disease. Prostate cancer is treated by experts such as urologists, radiation oncologists, and medical oncologists. 

Global Oncolytic Virus Therapies Market

Report ID: PNPH1167 Industry: Pharma & Biotech Therapy Area: Oncology

The market size of the global?oncolytic virus therapies in the year 2019 is valued at 84.3 million and is predicted to reach 962 million by the year 2030 at an 26.28% CAGR during the forecast period.Oncolytic viruses (OVs) are either naturally occurring or genetically modified. They only target and kill cancer cells while leaving healthy cells unharmed. This treatment, a cutting-edge approach to treating cancer patients, has had positive outcomes. Oncolytic virus therapies, which target DNA or RNA inside or outside the body, overlap biomedical research fields with similar therapeutic goals. Through genetic modification, these therapies attempt to treat an illness. The need to treat these chronic illnesses and the rising cancer incidence are the main factors driving the market growth.

Global Oncology Nutrition Market

Report ID: PNPH1166 Industry: Pharma & Biotech Therapy Area: Others

Oncology Nutrition Market Forecast to 2030 - By Cancer type (Head and Neck Cancers, Stomach and Gastrointestinal Cancers, Lung Cancer, Breast Cancer, Blood Cancer, Other Cancers) and Geography.The term

Global Nasal drug Delivery Market

Report ID: PNPH1164 Industry: Pharma & Biotech Therapy Area: Others

The parenteral route, commonly referred to as the nasal drug delivery system, is an alternate method of medication administration.The market for nasal drug delivery technology is predicted to expand throughout the course of the forecast period as a result of factors such as rising chronic illness incidence, advanced technology, and rising demand for nasal drug delivery systems. Additionally, it is anticipated that increasing self-administration practises will present more growth opportunities for companies involved in the nasal drug delivery technology market. 

Leukemia Therapeutics Market

Report ID: PNPH1163 Industry: Pharma & Biotech Therapy Area: Oncology

Leukemia is a type of blood cancer caused by gene mutation leading to abnormal development of WBCs in the bone marrow and causes leukemia.Leukemia is also caused due to risk factors such as genetic disorders such as Down syndrome, previous cancer treatments, exposure to chemicals, smoking, and family history of leukemia or other blood disorders. The major types of leukemia are Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), and Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL). The majority of the AML, CML & CLL cases could be observed in adult populations, and ALL could be seen in all age groups. Leukemia treatment is based on its type, age, and ability to cope-up with the treatments.

Global Hemophilia Treatment Market

Report ID: PNPH1161 Industry: Pharma & Biotech Therapy Area: Hematological Disorders

Hemophilia is a commonly inherited group of bleeding disorders in which there is a problem with the blood clotting process. It can reflect sudden bleeding, continuous bleeding after surgery, and injuries. It contains various clotting factors that help stop bleeding, if there is any mutation in these clotting genes that mutation can inhibit the clotting protein factor, necessary to form a blood clot.

Fertility Supplement Market

Report ID: PNPH1160 Industry: Pharma & Biotech Therapy Area: Reproductive Health

Fertility supplements contain micronutrients, which are vitamins and minerals that the human body needs in small amounts. Some people (male or female) may take these supplements to increase their chances of a healthy pregnancy. Majorly supplements are playing significant roles in women’s reproductive health and are essential for many functions, including menstruation and ovulation, thyroid function, and egg quality and maturation.

Epilepsy Therapeutics Market

Report ID: PNPH1002 Industry: Pharma & Biotech

Epilepsy is a heterogeneous condition requiring individualized treatment based largely on a patient’s seizure syndrome and seizure type.The epilepsy treatment market was valued at USD 10.9 billion in 2021 and is expected to reach USD 14.6 billion by 2027, exhibiting a CAGR of 5.2% during the forecast period 2022-2027. Due to a surge in the prevalence of neurological disorders among epilepsy diseases, increases in innovative medicines & extensive research of epilepsy therapeutics around the globe, and a rise in the adoption of therapeutics by patients.

Anal Cancer Market

Report ID: PNPH1158 Industry: Pharma & Biotech Therapy Area: Oncology

Anal cancer is generally a rare type of malignancy that affects the colon and rectum. Some of the symptoms associated with anal cancer include anal or rectum bleeding, a lump near the anus, pain around the anus, itching in the anus, discharge from the anus, changes in bowel habits, and others. It can be caused due to several risk factors such as human papillomavirus (HPV) infection, excessive smoking, and medical history of vaginal, cervical, or vulvar cancers.

Breast Cyst Treatment Market

Report ID: PNPH1159 Industry: Pharma & Biotech Therapy Area: Oncology

A breast cyst is a noncancerous (benign), fluid-filled sac in the breast. Developed as a result of fluid accumulation inside the breast glands, this is found in women aged 20 to 50 years and it can be single or multiple. A cyst may feel like a grape or water balloon or firm.

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.